


Vlasroot Group
Venture Capital and Private Equity Principals • Amsterdam, North Holland, Netherlands • 1-10 Employees
Company overview
| Headquarters | Admiraal de Ruyterweg 175, Amsterdam, Nederland 1056 GC, NL |
| Phone number | +31655146066 |
| Website | |
| NAICS | 52391 |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at Vlasroot Group
Pascal Lambers
Founder
Vlasroot Group Email Formats
Vlasroot Group uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@vlasroot.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@vlasroot.com | 100% |
About Vlasroot Group
Vlasroot is a group of informal investors who focus on SME’s with growth potential, a proven ‘track record’ and a strong management team. Companies that provide real solutions for real problems. We offer an experienced team with a considerable experience in both business and investing and know how to make companies grow. We help companies to raise the bar and reach targets. We believe in co-creation and offer our network and expertise to our portfolio companies. Vlasroot has invested in the following companies: RiboPro - www.ribopro.eu RiboPro is a knowledge-driven biotech start-up focussed on the R&D, production and sale of custom messenger RNA products to customers worldwide. Via our high-quality, high-potency RNA products, which are used as powerful research tools and therapeutics, we enable academic, biotech and pharma researchers to do better science, create more powerful medicines and develop vaccines faster than ever before. RiboPro was founded by Sander van Asbeck (CEO), Dr. Jürgen Dieker (CSO) and Dr. Roland Brock. NBCL - www.nbcl.nl NBCL (Novel Biomarkers Catalyst Lab) was founded in 2012 and is located at our offices and laboratories at Kerkenbos in Nijmegen the Netherlands. NBCL has an experienced immunoassay development team and works on the development of new immunoassays on the NBCL platform. NBCL has an assay development laboratory and can perform small scale immunoassay production. NBCL is dedicated to the development and commercialisation of immunoassays that are or become important diagnostic tools in clinical management.
Vlasroot Group revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vlasroot Group has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Vlasroot Group has never raised funding before.
Vlasroot Group Tech Stack
Discover the technologies and tools that power Vlasroot Group's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Miscellaneous
Frequently asked questions
4.8
40,000 users



